Kensey Nash to Present at the Jefferies 3rd Annual Healthcare Conference

* Reuters is not responsible for the content in this press release.

Wed Jun 10, 2009 11:33am EDT

EXTON, Pa., June 10 /PRNewswire-FirstCall/ -- Kensey Nash Corporation (Nasdaq:
KNSY) is scheduled to present at the Jefferies 3rd Annual Healthcare
Conference on Thursday, June 18, 2009. 

Joseph W. Kaufmann, Kensey Nash's President & CEO, will deliver the Company's
presentation, beginning at approximately 9:00 a.m. (ET).  To hear the live
webcast of the Kensey Nash presentation go to
http://www.wsw.com/webcast/jeff35/knsy/.  The presentation materials will also
be available on the company's website (www.kenseynash.com) beginning at 9:00
a.m. (ET) on Thursday, June 18, 2009.

About Kensey Nash Corporation.  Kensey Nash Corporation is a leading medical
technology company providing innovative solutions and technologies for a wide
range of medical procedures.  The Company provides an extensive range of
products into multiple medical markets, including sports medicine, spine, and
endovascular.  Many of the products are based on the Company's significant
expertise in the design, development, manufacturing and processing of
absorbable biomaterials, which has led to partnerships to commercialize
technologies.  The Company is known as a pioneer in the field of arterial
puncture closure, as the inventor and developer of the Angio-Seal(TM) Vascular
Closure Device, which is licensed to St. Jude Medical, Inc.

SOURCE  Kensey Nash Corporation

Joseph W. Kaufmann, President and Chief Executive Officer of Kensey Nash
Corporation, +1-484-713-2100
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.